What Verdica's 799 score means for APDM PHARMS
APDM PHARMS holds a composite score of 799 out of 850, placing it in the "strong" performance band (740–799). This score reflects compliance and operational data drawn from state board of pharmacy records, FDA filings, and DEA tracking systems. A score in this range indicates that the provider meets or exceeds baseline regulatory requirements across most dimensions, with minimal red flags in the indexed data.
For a business owner or consumer evaluating pharmacy providers, a 799 score suggests reasonable confidence in the entity's regulatory standing. It is not a perfect score—the 51-point gap to the maximum indicates room for improvement or minor compliance variances—but it does signal that APDM PHARMS has not triggered significant enforcement actions or licensing suspensions in the systems Verdica monitors. Readers should interpret this as "approved for consideration" rather than "no further due diligence needed."
How the sub-scores break down
Product Approval (850/850): This perfect sub-score reflects APDM PHARMS's alignment with FDA product registration and listing requirements. In practical terms, all products indexed for this entity appear to have current FDA approval or proper exemption status. A score of 850 in this dimension is the strongest possible signal—it means no flagged unapproved drugs, no recalled products pending resolution, and no obvious gaps in product documentation on file with federal regulators.
Manufacturer Profile (720/850): This mid-range sub-score is the lowest of the three and likely reflects either routine compliance observations or minor variances in facility inspection records. Manufacturer profile scores are informed by FDA inspection histories and Good Manufacturing Practice (GMP) compliance data. A score of 720 suggests the entity operates within acceptable bounds but may have received inspection findings, quality system notes, or other non-critical observations. This is not unusual in the pharmacy industry and does not necessarily indicate systemic problems.
FDA Compliance (830/850): This strong sub-score indicates APDM PHARMS maintains current FDA registrations, reporting obligations, and adverse event tracking requirements. An 830 score means the entity has not accumulated serious compliance gaps in submissions, recalls, or regulatory correspondence tracked by the FDA. Minor discrepancies or late filings could account for the 20-point gap from perfect, but nothing severe enough to warrant warning letters or enforcement actions.
What regulators track for pharmacy providers
State boards of pharmacy maintain licensing records, disciplinary histories, and operational permits for all pharmacy providers. Verdica indexes these records to flag suspensions, revocations, or active complaints. The FDA monitors product approvals, manufacturing facilities, adverse event reports, and recalls through its database systems. Scores improve when entities maintain current registrations, respond promptly to inspection findings, and report safety data as required. DEA compliance tracking focuses on controlled substance handling, record-keeping, suspicious order reporting, and license maintenance. Infractions in any of these areas—such as failure to report diversion, improper record retention, or lapsed licenses—lower scores significantly.
Pharmacy providers can face score reductions for unresolved inspection findings, product recalls, licensing delays, or regulatory correspondence indicating non-compliance. Conversely, scores improve with clean inspection histories, prompt regulatory responses, and full product approval documentation.
Bottom line
APDM PHARMS presents as a strong compliance performer with no major red flags in indexed regulatory data. The 799 composite score and perfect product approval rating support confidence in the entity's basic regulatory standing. Before committing to a business relationship, cross-check current state pharmacy licensing, confirm any recent FDA inspection reports, and verify DEA controlled substance handling compliance through public records.